Mark S. Colella joined 5AM Ventures in 2008 from BÂRRX Medical, a Bay Area start-up gastrointestinal medical device company, where he was head of marketing. Prior to BÂRRX, he held various management roles with Stryker, focused in the fields of orthopedics, laparoscopy, urology, gynecology, and general minimally invasive surgery. Mr. Colella brings over a decade of operational experience in healthcare, focused primarily in the areas of marketing, product development and business development. In addition, he spent four years with Primrose Alzheimer’s Living, Inc., an early-stage healthcare service start-up company, and one year working for Versant Ventures. Mr. Colella currently serves on the boards of Semprus Biosciences and represents 5AM as a board observer to WaveRx, TivaMed and Epic Pharmaceuticals. Mr. Colella earned a B.S. in Biology from Williams College and earned his M.B.A. from Northwestern University, the Kellogg School of Management. Mr. Colella is based in the Menlo Park, CA office.
